Get the latest Science News and Discoveries

Ficlatuzumab plus chemotherapy may benefit patients with relapsed/refractory AML

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of AML

AML

Related news:

Oncotarget: Activation of plasmacytoid dendritic cells promotes AML-cell fratricide

Investigational combo therapy shows benefit for TP53 mutant MDS and AML patients

New drug combination shows promise as powerful treatment for AML

« Wildlife Trade Brings Huge Risk of The Next Outbreak, Study of Over 800 Species Shows

Jumping Spiders Seem to Have a Cognitive Ability Only Previously Found in Vertebrates »